310275
New York Opinion Leaders' Support for Point of Sale Policies: Impact of Awareness of Recent Successes
In 2011, we completed interviews with 679 (59%) of the census of New York county-level and NY City borough-level elected leaders and public health officials (N=1148). 38.3% of participants somewhat or strongly supposed a policy banning tobacco sales in pharmacies and 58.8% supported a ban on tobacco product displays. Participants who reported higher awareness of the policy issue were more likely to support it. This study will be re-administered in Spring 2014 and changes in policy support and issue awareness assessed. Additional dependent measures will include awareness of CVS ban on tobacco sales, the Haverstraw product display ban, and Providence ordinances. Open-text items will explore the extent to which the CVS policy influenced participant support.
We hypothesize that opinion leader support for POS policies will increase and that support will be highest among those who reported higher awareness of these policies. We also hypothesize that as a result of the CVS experience, fewer participants will cite negative business effects as a reason for opposing a pharmacy ban.
Learning Areas:
Public health or related public policyLearning Objectives:
Describe county-level elected official support for tobacco control policies at the point-of-sale.
Describe county-level elected official awareness of tobacco control policies at the point-of-sale including the NYC ban on coupon redemption and promotions and the CVS policy to cease selling tobacco products.
Assess the extent to which awareness of tobacco-focused POS policies in the news is associated with local elected official support for tobacco-focused POS policies.
Keyword(s): Public Health Policy, Tobacco Control
Qualified on the content I am responsible for because: I have been working in tobacco control research and evaluation for more than 15 years. I have led the evaluation of the NY TCP for 7+ years.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.